Gallic acid fermentation by metabolically engineered Escherichia coli producing p-hydroxybenzoate hydroxylase from Hylemonella gracilis NS1
The Journal of General and Applied Microbiology · 2023 · 69 (6) · 301-308
DOI: 10.2323/jgam.2023.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of General and Applied Microbiology, 2023. Verfasst von Nozomi Katsuki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life and Environmental Sciences, Microbiology Research Center for Sustainability, University of Tsukuba. Hauptthemen laut MEDLINE: Gallic Acid, Fermentation, Escherichia coli, Metabolic Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Life and Environmental Sciences, Microbiology Research Center for Sustainability, University of Tsukuba.
Zitieren
APA
Katsuki, N., Masuo, S., Nukui, N., Minakawa, H., & Takaya, N. (2023). Gallic acid fermentation by metabolically engineered Escherichia coli producing p-hydroxybenzoate hydroxylase from Hylemonella gracilis NS1. The Journal of General and Applied Microbiology, 69(6), 301-308. https://doi.org/10.2323/jgam.2023.08.004
Vancouver
Katsuki N, Masuo S, Nukui N, Minakawa H, Takaya N. Gallic acid fermentation by metabolically engineered Escherichia coli producing p-hydroxybenzoate hydroxylase from Hylemonella gracilis NS1. The Journal of General and Applied Microbiology. 2023;69(6):301-308. doi:10.2323/jgam.2023.08.004
BibTeX
@article{Katsuki2023,
author = {Katsuki, Nozomi and Masuo, Shunsuke and Nukui, Noriyuki and Minakawa, Hajime and Takaya, Naoki},
title = {Gallic acid fermentation by metabolically engineered Escherichia coli producing p-hydroxybenzoate hydroxylase from Hylemonella gracilis NS1},
journal = {The Journal of General and Applied Microbiology},
year = {2023},
volume = {69},
number = {6},
pages = {301--308},
doi = {10.2323/jgam.2023.08.004}
}
EUVIMED